Loading…
iShares U.S. Pharmaceutical ETF
The share price is 5.0% below its 52-week high of $108.66. It pays a dividend yielding 1.42%. 2 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $2.58M. In that quarter, 1 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Major managers that reported this stock in their latest 13F.